Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12720544
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of RPS6KB2 mRNA | increases expression | 18180321
|
D020001 |
1-Butanol |
1-Butanol results in decreased activity of RPS6KB2 protein | decreases activity | 12087098
|
C038753 |
leptomycin B |
leptomycin B results in decreased activity of RPS6KB2 protein | decreases activity | 12087098
|
D010656 |
Phenylephrine |
bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12720544
|
D010656 |
Phenylephrine |
Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12720544
|
D010656 |
Phenylephrine |
rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12720544
|
D010712 |
Phosphatidic Acids |
MTOR protein affects the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein] | affects reaction|increases activity | 12087098
|
D010712 |
Phosphatidic Acids |
Phosphatidic Acids results in increased activity of RPS6KB2 protein | increases activity | 12087098
|
D010712 |
Phosphatidic Acids |
Sirolimus inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12087098
|
D010712 |
Phosphatidic Acids |
wortmannin inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12087098
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RPS6KB2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12720544
|
C085746 |
rottlerin |
rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12720544
|
C085746 |
rottlerin |
rottlerin results in decreased activity of RPS6KB2 protein | decreases activity | 12720544
|
D020123 |
Sirolimus |
MTOR protein inhibits the reaction [Sirolimus results in decreased activity of RPS6KB2 protein] | decreases activity|decreases reaction | 12087098
|
D020123 |
Sirolimus |
Sirolimus inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12087098
|
D020123 |
Sirolimus |
Sirolimus results in decreased activity of RPS6KB2 protein | decreases activity | 12087098
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of RPS6KB2 mRNA | increases expression | 18175754
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein] | decreases reaction|increases activity | 12087098
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.63 | 16434500 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.21 | 17460149 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.70 | 7820390 |
MESH:D001321 |
Autistic Disorder |
|
Sirolimus |
3.20 | 21115397 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.26 | 19483382 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.97 | 11985600 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.70 | 15306635 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20953835 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.46 | 17123778 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Sirolimus |
3.17 | 19335982 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.14 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Sirolimus |
3.59 | 19435901 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
3.59 | 15728586 11754973 16170337 11179087 17287366 17124262 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.91 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.89 | 15894690 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.87 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Prazosin |
4.72 | 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
4.72 | 15131321 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
7.65 | 8273558 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.65 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.87 | 20131406 19236843 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Sirolimus |
4.53 | 19435901 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.13 | 19772884 16221962 19176532 18467677 |
MESH:D006930 |
Hyperalgesia |
|
Prazosin |
4.95 | 12727271 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
3.11 | 8949925 12717712 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
11.38 | 12791704 18502941 |
MESH:D006984 |
Hypertrophy |
|
Sirolimus |
11.38 | 19211884 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
3.94 | 8273558 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.77 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.77 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
12.77 | 14714311 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.84 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Sirolimus |
2.84 | 17050028 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.85 | 20007298 16377806 15890375 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.18 | 14737004 |
MESH:D008545 |
Melanoma |
|
Sirolimus |
3.23 | 19282848 |
MESH:D009062 |
Mouth Neoplasms |
|
Sirolimus |
4.79 | 19435901 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.99 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.10 | 16427766 11399458 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.14 | 11985600 |
MESH:D010300 |
Parkinson Disease |
|
Sirolimus |
3.77 | 19682553 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.10 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.32 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.36 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.36 | 18760546 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.94 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.86 | 7327846 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.14 | 16045194 16684133 |
MESH:D014402 |
Tuberous Sclerosis |
|
Sirolimus |
5.69 | 21115397 18495876 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.18 | 14652134 |
MESH:D014605 |
Uveitis |
|
Sirolimus |
5.81 | 1336536 |